Read More Healthcare Industry News Sirtex Medical earns FDA nod for SIR-Spheres® Y-90 in treating unresectable liver cancer in U.S. Sirtex Medical gains FDA approval for SIR-Spheres® Y-90 in treating unresectable hepatocellular carcinoma, expanding its U.S. radioembolization therapy scope. byPallavi MadhirajuJuly 8, 2025